Advertisement
Screener

Citius Oncology, Inc. (CTOR) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.8 / 5 stars · 68/120 Roast Me

Citius Oncology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

Citius Oncology, Inc. (CTOR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 85.00% for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-23.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2025-12-23

  • Citius Oncology, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 85.00%, a 2.30% decline from fiscal 2024.
  • Citius Oncology, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 87.00%, a 4.40% decline from fiscal 2023.
  • Citius Oncology, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 91.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month
2025-09-3085.00%
10-K · filed 2025-12-23
2024-09-3087.00%
10-K · filed 2025-12-23
2023-09-3091.00%
10-K · filed 2024-12-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anixa Biosciences Inc (ANIX)United States$0.096B
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
ProMIS Neurosciences Inc. (PMN)$0.102B
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Equillium, Inc. (EQ)United States$0.109B-11.27